Skip to content
Speciality Medicines logo

Speciality Medicines IPO

Check allotment status
Issue price
₹124
Listing price
₹124
0.00%
Current price
₹169.4
+36.61%
Subscribed
2.19x
Issue size
₹29 Cr
Listed on
30 Mar 2026

IPO timeline

  1. Opens
    20 MarFri
  2. Closes
    24 MarTue
  3. Allotment
    25 MarWed
  4. Refunds
    27 MarFri
  5. Demat credit
    27 MarFri
  6. Listing
    30 MarMon

Issue details

Price band
₹117 – ₹124 per share
Issue size
₹29 Cr
Fresh issue
Not available
Offer for sale
Not available
Issue type
NII Shares Offered
Face value
₹10 per share
Lot size
1,000 shares
Minimum investment
₹1,24,000
Listing on
BSE SME
Exchange code
544738.BO · 7653

Lot size and investment

ApplicationLotsSharesAmount
Retail (Min)11,000₹1,24,000
Retail (Max)11,000₹1,24,000
HNI (Min)22,000₹2,48,000

Reservation

QIB
21,000 shares (0.95% of the Offer)
NII
10,89,000 shares (49.50% of the Offer)
Retail
10,90,000 shares (49.55% of the Offer)

Allotment status

Registrar: Skyline Financial Services Private Limited

The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).

Check allotment on Skyline Financial Services
  1. 1Open the registrar's allotment page and select this IPO from the list.
  2. 2Enter your PAN, application number or DP / Client ID.
  3. 3Submit to see the number of shares allotted, if any.
Basis of allotment
25 Mar 2026
Refunds initiated
27 Mar 2026
Shares credited to demat
27 Mar 2026
Listing
30 Mar 2026

Grey market premium (GMP)

Updated 29 Mar 2026, 07:10 PM IST
Current GMP
₹0
—
Estimated listing price
₹124
Issue price ₹124
Highest
₹0
18 Mar
Lowest
₹0
18 Mar

GMP by day (₹ per share)

Day-wise GMP table
DateGMPPremiumEst. listing
29 Mar 2026₹0—₹124
28 Mar 2026₹0—₹124
25 Mar 2026₹0—₹124
24 Mar 2026₹0—₹124
23 Mar 2026₹0—₹124
21 Mar 2026₹0—₹124
20 Mar 2026₹0—₹124
19 Mar 2026₹0—₹124
18 Mar 2026₹0—₹124
Kostak rate
₹0

GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.

Subscription status

Updated 24 Mar 2026, 05:11 PM IST
Overall subscription
2.19x
Fully subscribed
  • QIB96.24x
  • NII (HNI)1.77x
  • Retail0.85x
CategoryShares offeredShares bid forSubscribed
Qualified Institutional Buyers (QIB)21,00020,21,00096.24x
Non-Institutional Investors (NII)12,39,00021,94,0001.77x
Retail Individual Investors (RII)10,90,0009,22,0000.85x
Total23,50,00051,37,0002.19x

Financials

Amounts in Rs. Crore
P/E Ratio
10.49
EPS (₹)
11.82
RoCE
33.39%
RoNW
28.30%
PAT Margin
14.77%

Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.

Period ended31 Oct 202531 Mar 202531 Mar 2024
Assets45.5739.9822.68
Total Income36.9358.5427.66
Profit After Tax6.068.612.93
EBITDA6.519.095.26
NET Worth36.4730.4215.06
Reserves and Surplus30.0423.989.95
Total Borrowing4.815.052.86
CompanyIssue sizeP/ERoNWPAT marginSubscribedListing gain
Speciality Medicines
This IPO
₹29 Cr10.4928.30%14.77%2.19x0.00%
Avience Biomedicals
SME · listed 25 Jun 2026
₹30.24 Cr16.5649.89%15.86%385.4x+90.00%
Himalaya Nutravedics India
SME · listed 29 Sep 2026
₹26.5 Cr12.6345.12%17.16%2.24x+11.32%
ABH Healthcare
SME · listed 1 Sep 2026
₹34.98 Cr20.6939.07%10.74%1.42x-2.94%
Bio Medica Laboratories
SME · listed 29 May 2026
₹52 Cr13.4599.59%25.64%2.31x-20.00%
Goldline Pharmaceutical
SME · listed 19 May 2026
₹12 Cr13.9327.37%10.09%781.85x+38.95%
Pramodini Medicare
SME · listed 19 Aug 2026
₹69.04 Cr14.9732.69%27.90%3.66x+1.69%

Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.

IPO objectives

₹50.66 Cr total

How Speciality Medicines plans to use the money raised, as stated in the offer document.

  1. Setting up of Research and Development (R&D) Centre at Revenue City Survey No. RV1/NA/61/1/50, Moje, Manda, Tal. Umargam, Dist. Valsad, Gujarat₹12.68 Cr
  2. Product Registration in International Markets and Product Development for sale in international markets₹2.99 Cr
  3. Funding for Marketing and Promotional Activities₹1.66 Cr
  4. To Meet Working Capital Requirements₹8 Cr
  5. General Corporate Purposes
  6. Total₹25.33 Cr

About Speciality Medicines

Speciality Medicines Limited was established with the objective of catering to the growing demand for niche and high-value pharmaceutical products in India. Over the years, the company has built its presence in the healthcare sector by focusing on specialised therapeutic segments such as critical care, oncology, and chronic disease management. Promoted by experienced professionals from the pharmaceutical industry, the company has developed strong relationships with hospitals, healthcare institutions, and distributors across key regions. The company’s business model revolves around sourcing, marketing, and distribution of speciality drugs, along with a focus on quality and regulatory compliance. It offers a diverse portfolio of branded and generic medicines, targeting both domestic and selected international markets. By leveraging an asset-light approach and an efficient supply chain network, Speciality Medicines Limited aims to scale its operations while maintaining consistent product availability and expanding its reach in the healthcare ecosystem.

Promoters and shareholding

Parth B Goyani and Goyani Sumit Babubhai

Promoter holding, pre-issue
59.28%
Promoter holding, post-issue
43.44%

Registrar, lead managers and documents

Registrar

Skyline Financial Services Private Limited

011-26812682

ipo@skylinerta.com

Lead manager

Company contact

913, One World West, S.No.396, FP 119, Village-Vejalpur, Ahmadabad City, Ahmedabad, Gujarat, 380051

+91 22 4604 5344

investors.grievances@specialitymedicine.com

Speciality Medicines IPO: common questions

1.When does the Speciality Medicines IPO open and close?

The Speciality Medicines IPO opens on 20 Mar 2026 and closes on 24 Mar 2026.

2.What is the price band of the Speciality Medicines IPO?

The price band is ₹117 – ₹124 per share, with a lot size of 1,000 shares and a minimum investment of ₹1,24,000.

3.What is the size of the Speciality Medicines IPO?

The issue size is ₹29 Cr (NII Shares Offered).

4.What is the GMP of the Speciality Medicines IPO?

The last reported grey market premium is ₹0 per share as of 29 Mar 2026, 07:10 PM IST. GMP is unofficial and changes frequently.

5.When is the Speciality Medicines IPO allotment?

The basis of allotment is expected on 25 Mar 2026. Allotment status can be checked with the registrar, Skyline Financial Services Private Limited.

6.When will the Speciality Medicines IPO list?

The shares listed on 30 Mar 2026 on BSE SME.

7.Who is the lead manager of the Speciality Medicines IPO?

The book running lead manager is Unistone Capital, and the registrar is Skyline Financial Services Private Limited.

8.What will the money raised in the Speciality Medicines IPO be used for?

As stated in the offer document, the proceeds are for: Setting up of Research and Development (R&D) Centre at Revenue City Survey No. RV1/NA/61/1/50, Moje, Manda, Tal. Umargam, Dist. Valsad, Gujarat; Product Registration in International Markets and Product Development for sale in international markets; Funding for Marketing and Promotional Activities; To Meet Working Capital Requirements; General Corporate Purposes.

9.How can my company launch an IPO like Speciality Medicines?

Start with an IPO readiness assessment: eligibility for the NSE Emerge or BSE SME platform, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.

For business owners

Your company could be the next listing

Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.

  • Eligibility check against NSE Emerge, BSE SME and Main Board norms
  • Indicative valuation and issue size for your business
  • A clear timeline from readiness to listing day

Check if your business can list

Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.

Prefer to talk? Call +91 92130 20393